MD Magazine (2/5, Kunzmann) reports, “A pair of prediction tool models assessing the psychiatric adverse effects of levetiracetam show that women and patients with comorbid depression or anxiety are significantly more likely to suffer an adverse effect when taking the” medication as a treatment for epilepsy, researchers found. The findings of the 1,173-patient study were published online Jan. 28 in JAMA Neurology.
Related Links:
— “Females, Previous Psychiatric Patients at Greater Risk of Adverse Levetiracetam Effects, “Kevin Kunzmann, MD Magazine, February 5, 2019